Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,561.69
(
0.55%
)
US TECH 100
29,428.00
(
0.86%
)
Dow Jones
50,597.91
(
-0.09%
)
Brent Oil
92.81
(
0.40%
)
Bitcoin
73,383.06
(
-2.01%
)
News Focus
News Focus
Post# of 257651
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123032
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: masterlongevity post# 73433

Thursday, 02/19/2009 7:47:54 PM

Thursday, February 19, 2009 7:47:54 PM

Post# of 257651
Addendum re MS market shares: NVS is now selling Extavia in Europe, which is a knockoff of Betaseron (#msg-35002657). Going forward, NVS’ Extavia sales will have to be tallied to get an accurate reading of the market shares.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today